Grandiflorenic acidCAS# 22338-67-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 22338-67-6 | SDF | Download SDF |
PubChem ID | 161387 | Appearance | Powder |
Formula | C20H28O2 | M.Wt | 300.44 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CC12CCCC(C1CCC34C2=CCC(C3)C(=C)C4)(C)C(=O)O | ||
Standard InChIKey | RJIPNPHMQGDUBW-MZWQVCBVSA-N | ||
Standard InChI | InChI=1S/C20H28O2/c1-13-11-20-10-7-15-18(2,16(20)6-5-14(13)12-20)8-4-9-19(15,3)17(21)22/h6,14-15H,1,4-5,7-12H2,2-3H3,(H,21,22)/t14?,15-,18+,19+,20?/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Pure Grandiflorenic acid can reproduce the uterine responses induced by zoapatle leaves aqueous extract , suggests that grandiflorenic acid may have antifertility effect. |
Targets | Estrogen receptor | Progestogen receptor |
Grandiflorenic acid Dilution Calculator
Grandiflorenic acid Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.3285 mL | 16.6423 mL | 33.2845 mL | 66.569 mL | 83.2113 mL |
5 mM | 0.6657 mL | 3.3285 mL | 6.6569 mL | 13.3138 mL | 16.6423 mL |
10 mM | 0.3328 mL | 1.6642 mL | 3.3285 mL | 6.6569 mL | 8.3211 mL |
50 mM | 0.0666 mL | 0.3328 mL | 0.6657 mL | 1.3314 mL | 1.6642 mL |
100 mM | 0.0333 mL | 0.1664 mL | 0.3328 mL | 0.6657 mL | 0.8321 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 9-Hydroxy-alpha-lapachone
Catalog No.:BCN5060
CAS No.:22333-58-0
- Methyl ferulate
Catalog No.:BCN4023
CAS No.:22329-76-6
- Platycodigenin
Catalog No.:BCN3183
CAS No.:22327-82-8
- Evodol
Catalog No.:BCN5059
CAS No.:22318-10-1
- Inolitazone dihydrochloride
Catalog No.:BCC1653
CAS No.:223132-38-5
- Inolitazone
Catalog No.:BCC1652
CAS No.:223132-37-4
- SEA0400
Catalog No.:BCC1941
CAS No.:223104-29-8
- Finasteride acetate
Catalog No.:BCC4204
CAS No.:222989-99-3
- Noladin ether
Catalog No.:BCC5756
CAS No.:222723-55-9
- SZL P1-41
Catalog No.:BCC8004
CAS No.:222716-34-9
- Chysin A
Catalog No.:BCN2020
CAS No.:22269-11-0
- ACBC
Catalog No.:BCC6584
CAS No.:22264-50-2
- Grandifloric acid
Catalog No.:BCN4669
CAS No.:22338-69-8
- Polygalacic acid
Catalog No.:BCN5898
CAS No.:22338-71-2
- FG2216
Catalog No.:BCC6402
CAS No.:223387-75-5
- GLP-2 (human)
Catalog No.:BCC5891
CAS No.:223460-79-5
- ONO 4817
Catalog No.:BCC2375
CAS No.:223472-31-9
- YM 58483
Catalog No.:BCC7817
CAS No.:223499-30-7
- CPA inhibitor
Catalog No.:BCC1500
CAS No.:223532-02-3
- Tiadinil
Catalog No.:BCC8070
CAS No.:223580-51-6
- K-115 free base
Catalog No.:BCC5501
CAS No.:223645-67-8
- Collagen proline hydroxylase inhibitor-1
Catalog No.:BCC1495
CAS No.:223663-32-9
- Collagen proline hydroxylase inhibitor
Catalog No.:BCC1494
CAS No.:223666-07-7
- Mirabegron (YM178)
Catalog No.:BCC3814
CAS No.:223673-61-8
The in vitro effect of grandiflorenic acid and zoapatle aqueous crude extract upon spontaneous contractility of the rat uterus during oestrus cycle.[Pubmed:6540830]
J Ethnopharmacol. 1984 Jun;11(1):87-97.
Montanoa tomentosa (zoapatle) is a Mexican plant popularly used for antifertility purposes and with promising characteristics for the development of a new oral contraceptive agent with uteroevacuant properties. In a previous pharmacological report we established the ambivalent myometrial response to zoapatle leaves aqueous extract (ZACE) depending on the animal species used and on the existence or absence of pregnancy. This fact could be useful in determining an appropriate medical use of zoapatle and suggests an interesting possible hormonal dependence in its mechanism of action. To elucidate the ZACE effect upon the pattern of uterine contractility in different hormonal stages, the rat uterus in vitro during oestrus cycle was studied. The aqueous crude extract of Montanoa tomentosa leaves produced different (or even opposite), effects on uterine motility during the distinct phases of the oestrus cycle in the rat. Furthermore, pure Grandiflorenic acid (GA), obtained from the phytochemical work up of this plant reproduced the uterine responses induced by ZACE. The action of zoapatle is discussed in relation to hormonal stage and to a probable adrenergic mechanism involved.